WallStSmart
MLAB

Mesa Laboratories Inc

NASDAQ: MLAB · TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS

$100.00
+4.43% today

Updated 2026-04-30

Market cap
$542.98M
P/E ratio
151.20
P/S ratio
2.19x
EPS (TTM)
$0.65
Dividend yield
0.65%
52W range
$55 – $130
Volume
0.1M

Mesa Laboratories Inc (MLAB) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+2.3%
Last 4 quarters
Revenue YoY growth
+3.6%
Most recent quarter
EPS YoY growth
+122.7%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+8.1%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+13.7%
2026-02-03
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-03$1.76-7.2%$80.50$91.53+13.7%
2025-11-06$2.75+19.6%$74.20$76.01+2.4%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$1.90$1.76-7.2%$65.13M+3.6%
2025-09-30$2.30$2.75+19.6%$60.74M+5.0%
2025-06-30$2.38$1.88-21.0%$59.54M+2.4%
2025-03-31$1.91$2.25+17.8%$62.13M+5.5%
2024-12-31$1.51$0.79-47.6%$62.84M+17.5%
2024-09-30$1.38$0.63-54.3%$57.83M+8.8%
2024-06-30$0.44$0.84+90.9%$58.17M+14.9%
2024-03-31$-0.11$3.70+3463.6%$58.90M+6.0%
2023-12-31$0.19$0.39+105.3%$53.47M
2023-09-30$0.16$-0.23-243.8%$53.16M
2023-06-30$-0.02$-0.10-400.0%$50.65M
2023-03-31$0.37$0.11-70.3%$55.59M

Frequently asked questions

Has Mesa Laboratories Inc beaten earnings estimates?
Mesa Laboratories Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +2.3% over the last 4 quarters.
How does MLAB stock react to earnings?
MLAB stock has moved an average of +8.1% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.
What is Mesa Laboratories Inc's revenue growth rate?
Mesa Laboratories Inc reported year-over-year revenue growth of +3.6% in its most recent quarter, with EPS growing +122.7% year-over-year.